FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2916451403> ?p ?o ?g. }

• W2916451403 abstract "Background Available outcomes data for anticoagulation therapy in adults with congenital heart disease ( CHD ) provide assessment of global risk of this therapy for CHD patients (a heterogeneous population), but the risk of complications for the different CHD diagnoses is unknown. The purpose of the study was to describe the indications for anticoagulation, and the incidence and risk factors for major bleeding complication in adults with tetralogy of Fallot. Methods and Results We queried Mayo Adult Congenital Heart Disease (MACHD) database for tetralogy of Fallot patients (aged ≥18 years) that received anticoagulation, 1990–2017. Of 130 patients (42±14 years, 75 men [58%]), warfarin and direct oral anticoagulants were used in 125 (96%) and 5 (4%), respectively because atrial arrhythmias (n=109), mechanical prosthetic valve (n=29), intracardiac thrombus (n=4), pulmonary embolism (n=6), stroke (n=3), and perioperative anticoagulation (n=44). The median hypertension, abnormal renal or liver function; stroke; bleeding history or predisposition; labile international normalized ratio; elderly (>65 years); drug or alcohol use score for the entire cohort was 1 (0–2) and 27 (21%) had hypertension, abnormal renal or liver function; stroke; bleeding history or predisposition; labile international normalized ratio; elderly (>65 years); drug or alcohol use score ≥2. There were 14 minor bleeding events (1.6% per year) and 11 major bleeding events (1.3% per year) in 8 patients during median follow‐up of 74 months (856 patient‐years). Mechanical prosthesis (hazard ratio 1.78, CI 1.29–3.77, P =0.021) and hypertension, abnormal renal or liver function; stroke; bleeding history or predisposition; labile international normalized ratio; elderly (>65 years); drug or alcohol use score ≥2 (hazard ratio 1.41, CI 1.03–3.88, P =0.046) were risk factors for major bleeding events. All‐cause mortality was higher in patients with major bleeding events (n=6, 75%) compared with patients without major bleeding events (n=25, 21%), P =0.001. Conclusions Considering the heterogeneity of the CHD population, data from the current study may be better suited for clinical decision‐making in tetralogy of Fallot patients." @default.
• W2916451403 created "2019-03-02" @default.
• W2916451403 creator A5024102005 @default.
• W2916451403 creator A5025226241 @default.
• W2916451403 creator A5032577440 @default.
• W2916451403 creator A5050660770 @default.
• W2916451403 creator A5061999743 @default.
• W2916451403 creator A5064005171 @default.
• W2916451403 creator A5071954654 @default.
• W2916451403 creator A5087907654 @default.
• W2916451403 date "2019-03-05" @default.
• W2916451403 modified "2023-09-26" @default.
• W2916451403 title "Outcomes of Anticoagulation Therapy in Adults With Tetralogy of Fallot" @default.
• W2916451403 cites W1536134154 @default.
• W2916451403 cites W1982483328 @default.
• W2916451403 cites W1995622797 @default.
• W2916451403 cites W2014710620 @default.
• W2916451403 cites W2102266956 @default.
• W2916451403 cites W2110851709 @default.
• W2916451403 cites W2112154343 @default.
• W2916451403 cites W2127985968 @default.
• W2916451403 cites W2140371358 @default.
• W2916451403 cites W2152584205 @default.
• W2916451403 cites W2157272547 @default.
• W2916451403 cites W2160775719 @default.
• W2916451403 cites W2221117040 @default.
• W2916451403 cites W2515851191 @default.
• W2916451403 cites W2525052087 @default.
• W2916451403 cites W2529569613 @default.
• W2916451403 cites W2587743013 @default.
• W2916451403 cites W2749540195 @default.
• W2916451403 cites W2989714602 @default.
• W2916451403 cites W3004050106 @default.
• W2916451403 cites W4205645630 @default.
• W2916451403 cites W73998748 @default.
• W2916451403 cites W79694754 @default.
• W2916451403 doi "https://doi.org/10.1161/jaha.118.011474" @default.
• W2916451403 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6474918" @default.
• W2916451403 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30803288" @default.
• W2916451403 hasPublicationYear "2019" @default.
• W2916451403 type Work @default.
• W2916451403 sameAs 2916451403 @default.
• W2916451403 citedByCount "1" @default.
• W2916451403 countsByYear W29164514032020 @default.
• W2916451403 crossrefType "journal-article" @default.
• W2916451403 hasAuthorship W2916451403A5024102005 @default.
• W2916451403 hasAuthorship W2916451403A5025226241 @default.
• W2916451403 hasAuthorship W2916451403A5032577440 @default.
• W2916451403 hasAuthorship W2916451403A5050660770 @default.
• W2916451403 hasAuthorship W2916451403A5061999743 @default.
• W2916451403 hasAuthorship W2916451403A5064005171 @default.
• W2916451403 hasAuthorship W2916451403A5071954654 @default.
• W2916451403 hasAuthorship W2916451403A5087907654 @default.
• W2916451403 hasBestOaLocation W29164514031 @default.
• W2916451403 hasConcept C126322002 @default.
• W2916451403 hasConcept C127413603 @default.
• W2916451403 hasConcept C141071460 @default.
• W2916451403 hasConcept C164705383 @default.
• W2916451403 hasConcept C207103383 @default.
• W2916451403 hasConcept C2776265017 @default.
• W2916451403 hasConcept C2776301958 @default.
• W2916451403 hasConcept C2778646171 @default.
• W2916451403 hasConcept C2779161974 @default.
• W2916451403 hasConcept C2780074459 @default.
• W2916451403 hasConcept C2780645631 @default.
• W2916451403 hasConcept C2908647359 @default.
• W2916451403 hasConcept C31174226 @default.
• W2916451403 hasConcept C44249647 @default.
• W2916451403 hasConcept C71924100 @default.
• W2916451403 hasConcept C72563966 @default.
• W2916451403 hasConcept C78519656 @default.
• W2916451403 hasConcept C99454951 @default.
• W2916451403 hasConceptScore W2916451403C126322002 @default.
• W2916451403 hasConceptScore W2916451403C127413603 @default.
• W2916451403 hasConceptScore W2916451403C141071460 @default.
• W2916451403 hasConceptScore W2916451403C164705383 @default.
• W2916451403 hasConceptScore W2916451403C207103383 @default.
• W2916451403 hasConceptScore W2916451403C2776265017 @default.
• W2916451403 hasConceptScore W2916451403C2776301958 @default.
• W2916451403 hasConceptScore W2916451403C2778646171 @default.
• W2916451403 hasConceptScore W2916451403C2779161974 @default.
• W2916451403 hasConceptScore W2916451403C2780074459 @default.
• W2916451403 hasConceptScore W2916451403C2780645631 @default.
• W2916451403 hasConceptScore W2916451403C2908647359 @default.
• W2916451403 hasConceptScore W2916451403C31174226 @default.
• W2916451403 hasConceptScore W2916451403C44249647 @default.
• W2916451403 hasConceptScore W2916451403C71924100 @default.
• W2916451403 hasConceptScore W2916451403C72563966 @default.
• W2916451403 hasConceptScore W2916451403C78519656 @default.
• W2916451403 hasConceptScore W2916451403C99454951 @default.
• W2916451403 hasIssue "5" @default.
• W2916451403 hasLocation W29164514031 @default.
• W2916451403 hasLocation W29164514032 @default.
• W2916451403 hasOpenAccess W2916451403 @default.
• W2916451403 hasPrimaryLocation W29164514031 @default.
• W2916451403 hasRelatedWork W1590954004 @default.
• W2916451403 hasRelatedWork W2039531178 @default.
• W2916451403 hasRelatedWork W2076292091 @default.
• W2916451403 hasRelatedWork W2157689025 @default.
• W2916451403 hasRelatedWork W2327379066 @default.

• next